SXRZ:F:F-iShares VII PLC - iShares Nikkei 225 ETF JPY Acc (EUR)

ETF | Others |

Last Closing

USD 230.75

Change

+1.55 (+0.68)%

Market Cap

USD 52.44B

Volume

15.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-05-22 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
UIM5:F UBS (Lux) Fund Solutions - MSC..

+0.38 (+0.74%)

USD 128.40B
SXR8:F iShares Core S&P 500 UCITS ETF..

+5.34 (+0.97%)

USD 114.04B
ZPDJ:F SPDR® MSCI Japan UCITS ETF

+0.32 (+0.56%)

USD 96.03B
XDNY:F Xtrackers MSCI Japan ESG Scree..

+0.10 (+0.68%)

USD 57.02B
XJSE:F Xtrackers II - Japan Governmen..

N/A

USD 53.72B
VUSA:F Vanguard Funds Public Limited ..

+0.22 (+0.22%)

USD 51.63B
0ZC:F Zscaler Inc

-0.95 (-0.43%)

USD 37.92B
BSND:F Danone SA

N/A

USD 33.83B
VGWL:F Vanguard FTSE All-World UCITS ..

+0.46 (+0.36%)

USD 24.77B
SXRV:F iShares NASDAQ 100 UCITS ETF U..

+5.00 (+0.47%)

USD 17.70B

ETFs Containing SXRZ:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -5.06% 32% F 46% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -5.06% 32% F 44% F
Trailing 12 Months  
Capital Gain 1.38% 37% F 55% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.38% 36% F 48% F
Trailing 5 Years  
Capital Gain 38.39% 44% F 53% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 38.39% 44% F 38% F
Average Annual (5 Year Horizon)  
Capital Gain 5.44% 54% F 55% F
Dividend Return 5.44% 51% F 47% F
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 12.57% 52% F 86% B+
Risk Adjusted Return 43.29% 48% F 61% D-
Market Capitalization 52.44B 99% N/A 96% N/A

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.